Ineffective control of Epstein–Barr virus infection is seen in MS: What is next?
Paulus Rommer(Medical University of Vienna), Hannes Vietzen(Medical University of Vienna), Hans Lassmann(University of Vienna), Thomas Berger(Medical University of Vienna), Elisabeth Puchhammer‐Stöckl(Medical University of Vienna)
Cited by 4
Related Papers
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
|Immunity|2017|3k
Oligodendrocytes: biology and pathology
|Acta Neuropathologica|2009|902
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
|Brain|2007|714
Myelin-oligodendrocyte glycoprotein antibody-associated disease
|The Lancet Neurology|2021|518
Multiple sclerosis: experimental models and reality
|Acta Neuropathologica|2016|508